Fig. 3: Performance evaluation of NF, motif, fragment features, and combined model (PCM score) in classification of pancreatic cancer to non-cancer subgroups.
From: Cell-free DNA testing for the detection and prognosis prediction of pancreatic cancer

a ROC curve analysis for the NF, motif, fragment and combined model (PCM score) in Training cohort. b ROC curve analysis for the NF, motif, fragment or combined model in Testing cohort. c External validation cohort 1. d External validation cohort 2. Source data are provided as a Source Data file.